Advertisement
Screener

Shattuck Labs, Inc. (STTK) Cash Flow Breakdown

2.8 / 5 stars · 68/120 Roast Me

Shattuck Labs, Inc. Cash Flow Breakdown

Cash flow breakdown shows where Shattuck Labs, Inc.'s cash came from and where it went: from running the business, from investing (buying or selling equipment, companies and investments) and from financing (borrowing, paying back loans, buying back shares, paying dividends). One row per year or quarter. A minus sign means cash went out. Financing is shown line by line: buybacks, dividends, debt paid back, new debt and the rest. All amounts are the filed figures for that period.

  • Fiscal year ended 2025-12-31: from running the business, $39.88M went out.
  • Fiscal year ended 2025-12-31: from investing, $7.89M went out.
  • Fiscal year ended 2025-12-31: from financing, $44.57M came in.
  • Fiscal year ended 2025-12-31: change in cash, $3.19M went out.

A minus sign means cash went out. * = worked out from the filed year-to-date figures (hover to see how); greyed = already counted inside another line.

Each year (12 month)

Fiscal year endRunning the businessFrom investingStaff share taxNew shares soldNot split outChange in cash
2025-12-31-$39.88M-$7.89M-$65.00K$44.48M-$3.19M
2024-12-31-$60.52M-$8.51M-$451.00K$1.24M*-$68.24M
2023-12-31-$81.23M$110.86M-$53.00K$48.17M$78.25M
2022-12-31-$94.50M$49.44M$0.00$0.00-$44.89M
2021-12-31-$57.12M-$10.44M$100.00K$1.83M*-$65.63M
2020-12-31-$33.66M-$146.32M$229.00K$330.64M*$150.88M
2019-12-31-$20.98M-$3.59M$0.00-$24.63M

Each quarter (3 month)

Quarter endRunning the businessFrom investingStaff share taxNew shares soldNot split outChange in cash
2026-06-30-$10.19M*-$144.95M*-$7.00K*$80.43M*$47.59M*
2026-03-31-$13.42M$23.85M-$262.00K$20.56M$5.50M*$36.23M
2025-12-31-$8.49M*$20.00M*$0.00*-$5.00K*
2025-09-30-$8.93M*-$43.49M*$0.00*$44.48M*
2025-06-30-$10.43M*$0.00*$0.00*$0.00*
2025-03-31-$12.03M$15.60M-$65.00K$0.00$3.51M
2024-12-31-$17.37M*$31.00M*$0.00*
2024-09-30-$16.07M*-$821.00K*-$4.00K*$0.00*
2024-06-30-$10.92M*-$5.41M*-$10.00K*$1.03M*
2024-03-31-$16.16M-$33.28M-$437.00K-$49.62M
2023-12-31-$19.42M*$55.85M*-$14.00K*$48.17M*
2023-09-30-$16.73M*-$14.55M*$0.00*$0.00*
2023-06-30-$18.62M*$24.43M*$0.00*
2023-03-31-$26.46M$45.13M-$39.00K$18.66M
2022-12-31-$23.84M*$31.46M*$0.00*
2022-09-30-$28.06M*$29.93M*$0.00*
2022-06-30-$16.32M*$3.43M*$0.00*
2022-03-31-$26.28M-$15.38M$0.00-$41.52M
2021-12-31-$18.72M*$25.60M*$0.00*
2021-09-30-$12.99M*$11.24M*$100.00K
2021-06-30-$14.34M*$14.84M*$1.26M*
2021-03-31-$11.07M-$62.13M$31.00K-$73.16M
2020-12-31-$14.04M*-$171.49M*$15.00K*$214.81M*
2020-09-30-$11.35M*$9.99M*$214.00K*-$1.30M*
2020-06-30$2.19M*$8.48M*-$6.00K*$82.69M*
2020-03-31-$10.45M$6.70M$6.00K$34.43M*$30.68M
2019-12-31-$7.62M*-$530.00K*$0.00*

Similar stocks

Stock NameCountryMarket CapPE Ratio
Neurogene Inc. (NGNE)$0.625B-4.46
BlossomHill Therapeutics, Inc. (BLSM)United States$0.647B
IMPACT BIOMEDICAL INC. (IBO)United States$0.611B66.47
Aquestive Therapeutics, Inc. (AQST)United States$0.606B-6.67
CorMedix Inc. (CRMD)United States$0.605B3.25
ZEVRA THERAPEUTICS, INC. (ZVRA)United States$0.668B14.61
CytomX Therapeutics, Inc. (CTMX)United States$0.598B-10.25
Monopar Therapeutics (MNPR)United States$0.598B-34.82
Altimmune, Inc. (ALT)United States$0.593B-6.43
Climb Bio, Inc. (CLYM)United States$0.683B-13.03